New blood marker can identify Parkinsonian diseases

In a study by researchers at Lund University the marker DOPA decarboxylase (DCC) was found to be elevated in individuals with Parkinson's disease as well as in people with other diseases that result in dopamine deficiency ...

Alzheimer's disease & dementia

Panel of 48 CSF proteins complements existing Alzheimer biomarkers

A panel of 48 proteins in the cerebrospinal fluid (CSF 48 panel) complements existing CSF biomarkers for Alzheimer disease (AD), according to a study published in the Sept. 6 issue of Science Translational Medicine.

Medical research

Urinary biomarkers can differentiate IC/BPS from other LUTDs

Urinary biomarkers can differentiate interstitial cystitis/bladder pain syndrome (IC/BPS) from other lower urinary-tract dysfunctions (LUTDs) in male patients, according to a study published online July 27 in the International ...

Diseases, Conditions, Syndromes

Developing a test for long COVID 'brain fog'

Two blood biomarkers could be predictive of cognitive deficits six and 12 months after a diagnosis of COVID-19, reports a new study published in Nature Medicine. These findings, based on data from more than 1,800 patients ...


A framework of biomarkers for brain aging

China and the world are facing severe population aging and an increasing burden of age-related diseases. Aging of the brain causes major age-related brain diseases, such as neurodegenerative diseases and stroke. Identifying ...

page 1 from 40